What is Virtus Biotech Clinical Trials ETF (BBC)?

Virtus Biotech Clinical Trials ETF (BBC) is an ETF in the Financial Services sector, Asset Management industry. View full analysis on Stocks360.

What is the current price of BBC?

The current price of BBC is $43.90. Prices are updated in real time on Stocks360.

What is BBC's market capitalization?

BBC's market capitalization is $39,513,556.00, placing it in the small-cap tier.

Virtus Biotech Clinical Trials ETF (BBC)

ETF analysis · AMEX · Financial Services · Asset Management

$43.90

Market Cap

$39.51M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.31

Day Range

$43.59 – $44.37

52-wk Range

$28.73 – $56.18

Avg Volume

N/A

Volume

19.80K

Virtus Biotech Clinical Trials ETF (BBC) is an exchange-traded fund in the Financial Services sector. Latest price: $43.90. Market cap $39.51M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-30 · $32.04 2026-10-29 · $43.90 (+37.02%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Virtus Biotech Clinical Trials ETF

This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.